Price
No data yet.
Social Signal Score
Analyst Ratings
11 analystsRevenue
$222.80M+145.60%Analyst Estimates
Consensus estimates, not results. Via Financial Modeling Prep.
Company Profile
- CEO
- Mikhael Nassif
- Sector
- Healthcare
- Industry
- Medical - Devices
- Employees
- 2,636
- Beta
- 1.86
- Country
- US
- Piotroski score
- 6 / 9 (Middling)
- Altman Z-score
- 1.31
Financials
Revenue
$222.80M+145.6%Net Income
$-11.90M-206.7%EBITDA
$28.00M+37.7%Free Cash Flow
$4.70M-27.5%EPS (diluted)
$-0.05-145.5%Shares Outstanding (diluted)
218.10M+113.8%Operating Expenses
$107.30MCash & Debt
$172.00MReturn of Capital
$0.00Revenue by Segment (annual)
$870.40MQuote
Valuation & Ratios
Returns & Efficiency
Revenue & Net Income (Annual)
| Fiscal Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2026 | $870.40M | $-7.90M | $-0.04 |
| 2025 | $894.66M | $-1.09B | $-5.03 |
| 2024 | $924.22M | $-9.42M | $-0.04 |
| 2023 | $822.45M | $-22.87M | $-0.12 |
| 2022 | $527.16M | $48.31M | $0.45 |
| 2021 | $468.46M | $60.88M | $0.57 |
| 2020 | $418.17M | $59.48M | $0.57 |
| 2019 | $414.19M | $60.18M | $0.58 |
| 2018 | $397.93M | $63.15M | $0.61 |
| 2017 | $358.28M | $43.79M | $0.43 |
| 2016 | $321.27M | $36.56M | $0.36 |
| 2015 | $283.07M | $33.53M | $0.34 |
| 2014 | $247.41M | $28.16M | $0.29 |
| 2013 | $207.53M | $27.19M | $0.28 |
Valuation
NEOGhas no positive reported earnings per share, so an earnings-multiple projection can't be built for it. Companies are valued on other measures at this stage — revenue growth, cash burn, or book value — none of which this calculator models.
Signal Score (90d)
50-37.50%Social Signal Score
Mentions (27)
- Newszacks.com·17d ago·Neutral
Neogen (NEOG) Up 6.7% Since Last Earnings Report: Can It Continue? Neogen (NEOG) reported earnings 30 days ago. What's next for the stock?
View source ↗ - Newsbusinesswire.com·19d ago·Neutral
Neogen® To Participate in 2026 UBS Global Healthcare Conference LANSING, Mich.--(BUSINESS WIRE)--Neogen® Corporation (NASDAQ: NEOG) announced today that the Company will participate in the 2026 UBS Global Healthcare Conference in Palm Beach Gardens, FL on Tuesday, November 10. About Neogen Neogen Corporation is committed to fueling a brighter future for global food security through the advancement of human and animal well-being. Harnessing the power of science and technology, Neogen has develope…
View source ↗ - Newszacks.com·33d ago·Positive
NEOG vs. WFCF: Which Food Safety Stock Has Better Prospects? Neogen beats Where Food Comes From in revenue growth and recovery potential, but higher debt and integration risks complicate the food safety stock showdown.
View source ↗ - Newsglobenewswire.com·38d ago·Negative
Neogen Corporation (NEOG) Shareholders Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation BENSALEM, Pa. , Oct. 15, 2026 (GLOBE NEWSWIRE) -- Law Offices of Howard G.
View source ↗ - Newsglobenewswire.com·39d ago·Negative
Securities Fraud Investigation Into Neogen Corporation (NEOG) Continues – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz LOS ANGELES, Oct. 14, 2026 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz continues its investigation of Neogen Corporation (“Neogen” or the “Company”) (NASDAQ: NEOG) on behalf of investors concerning the Company's possible violations of federal securities laws.
View source ↗ - Newsseekingalpha.com·45d ago·Positive
Neogen Corporation: Promising Recurring Demand With Food Safety I believe Neogen's recurring food safety products provide a foundation for its operating recovery. However, management has to execute carefully and proceed with the Petrifilm transition, which, if successful, should improve its cash flows long-term. Also, NEOG's recent genomics sale should give it extra flexibility, but we have to wait and see until we know how much its earnings may decrease as a result.
View source ↗ - Newsschaeffersresearch.com·45d ago·Positive
Dow, Nasdaq Futures Down Triple Digits on Higher Oil, Yields Treasury yields and oil prices weigh on stock futures this morning, with all three major indexes lower ahead of the open
View source ↗ - Newsmarketbeat.com·46d ago·Neutral
Neogen Investor Day Sets Path for Growth, 30% EBITDA Margin by 2031 Neogen NASDAQ: NEOG outlined a multi-year strategy at its first Investor Day, emphasizing a shift from business stabilization toward accelerated growth, higher margins and stronger cash generation. Management said the company has delivered positive core growth for four consecutive quarters and is targeting high-single-digit to low-double-digit long-term revenue growth, adjusted gross margins in the high-50% range, adjusted EBITD…
View source ↗ - Newsbusinesswire.com·46d ago·Negative
Neogen Outlines Strategy for Growth, Innovation and Margin Expansion at 2026 Investor Day LANSING, Mich.--(BUSINESS WIRE)--Neogen Corporation (NASDAQ: NEOG) today hosted its 2026 Investor Day, "Shaping the Future of Food Safety," in New York City, where the company's senior leadership team outlined a comprehensive strategy for sustained profitable growth and category leadership, and provided a framework under which it plans to achieve financial targets by fiscal year 2031. The event featured pre…
View source ↗ - Newsseekingalpha.com·46d ago·Positive
Neogen Corporation (NEOG) Analyst/Investor Day Transcript Neogen Corporation ( NEOG ) Analyst/Investor Day October 7, 2026 9:00 AM EDT Company Participants Bill Waelke Mikhael Nassif - CEO, President & Director Tamara Ranalli - Senior VP & GM of Global Food Safety Joe Freels - Senior VP & Chief Commercial Officer Jeremy Yarwood - Chief Scientific Officer Jim Walter R. Riggsbee - CFO & Senior Vice President Conference Call Participants Brandon Vazquez - William Blair & Company L.L.C.
View source ↗ - Newsbenzinga.com·46d ago·Neutral
Neogen Shifts Focus to Scale Profitable Growth Neogen Corp. (NASDAQ:NEOG) stock fell on Wednesday even after the company reported better-than-expected first-quarter financial results.
View source ↗ - Newszacks.com·47d ago·Negative
Compared to Estimates, Neogen (NEOG) Q1 Earnings: A Look at Key Metrics Although the revenue and EPS for Neogen (NEOG) give a sense of how its business performed in the quarter ended August 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
View source ↗ - Newsseekingalpha.com·47d ago·Positive
Neogen Corporation (NEOG) Q1 2027 Earnings Call Transcript Neogen Corporation (NEOG) Q1 2027 Earnings Call Transcript
View source ↗ - Newsmarketbeat.com·47d ago·Neutral
What Neogen (NEOG) Said on Its Q1 Earnings Call Neogen NASDAQ: NEOG reported fiscal 2027 first-quarter revenue of $222.8 million, with core growth of 8.1%, as the company cited improved commercial execution, product-line strength in food safety and animal safety, and progress on its Petrifilm manufacturing transition.
View source ↗ - Newszacks.com·47d ago·Positive
Neogen (NEOG) Q1 Earnings and Revenues Beat Estimates Neogen (NEOG) came out with quarterly earnings of $0.08 per share, beating the Zacks Consensus Estimate of $0.05 per share. This compares to earnings of $0.04 per share a year ago.
View source ↗ - Newsbusinesswire.com·49d ago·Negative
NEOG Investors Have Opportunity to Join Neogen Corporation Fraud Investigation with SBS Law LOS ANGELES--(BUSINESS WIRE)---- $NEOG--NEOG Investors Have Opportunity to Join Neogen Corporation Fraud Investigation with SBS Law.
View source ↗ - Newsmarketbeat.com·51d ago·Neutral
Neogen Shareholders Approve Board Elections, Pay and Equity Plan Amendments Neogen NASDAQ: NEOG shareholders approved all five proposals presented at the company's 2026 annual meeting, including the election of three directors, advisory approval of executive compensation, and amendments to the company's equity incentive and employee stock purchase plans.
View source ↗ - Newszacks.com·52d ago·Neutral
Unlocking Q1 Potential of Neogen (NEOG): Exploring Wall Street Estimates for Key Metrics Evaluate the expected performance of Neogen (NEOG) for the quarter ended August 2026, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.
View source ↗ - Newszacks.com·52d ago·Neutral
Neogen Stock Rallies 83% YTD: What's Driving the Surge? NEOG's 83% YTD rally reflects Food Safety momentum, Petrifilm expansion, solutions-based selling and a growing product pipeline.
View source ↗ - Newsbusinesswire.com·53d ago·Negative
Securities Fraud Investigation Into Neogen Corporation (NEOG) Announced – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz announces an investigation of Neogen Corporation (“Neogen” or the “Company”) (NASDAQ: NEOG) on behalf of investors concerning the Company's possible violations of federal securities laws.IF YOU ARE AN INVESTOR WHO LOST MONEY ON NEOGEN CORPORATION (NEOG), CLICK HERE TO INQUIRE ABOUT PO…
View source ↗ - Newsbenzinga.com·54d ago·Negative
Why is Neogen Stock Trading Lower on Tuesday? The U.S. Food and Drug Administration (FDA) issued a formal warning letter to Mike Nassif, president and CEO of Neogen Corp (NASDAQ:NEOG), related to Neogen Vet's HYCOAT (Hyaluronate Sodium Sterile Solution).
View source ↗ - Newsbenzinga.com·58d ago·Negative
Neogen Gears Up For Q1 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts Neogen Corporation (NASDAQ:NEOG) will release earnings for its first quarter after the closing bell on Tuesday, Oct. 6.
View source ↗ - Newsbusinesswire.com·68d ago·Negative
Neogen Announces First-Quarter Earnings Release Date LANSING, Mich.--(BUSINESS WIRE)--Neogen® Corporation (NASDAQ: NEOG) will issue its first-quarter earnings release after the closing of the market on October 6, 2026. Executives from the company will host a webcast and conference call beginning at 4:30 p.m. Eastern time, to discuss the financial results. The conference call can be accessed by dialing: Toll-Free - North America: 1-833-461-5787 International: (+1) 626-884-3620 Conference ID: 323 …
View source ↗ - Newszacks.com·73d ago·Neutral
Is This the Right Time to Add Neogen Stock to Your Portfolio? NEOG advances product innovation and recovers Animal Safety operations, but high debt and intense competition remain key risks.
View source ↗ - Newszacks.com·83d ago·Positive
Neogen Surges 102.8% in a Year: What's Driving the Rally? NEOG shares gain 102.8% in a year as R&D investments, Food Safety growth and improving Animal Safety conditions fuel momentum despite key risks.
View source ↗ - Newszacks.com·90d ago·Positive
Neogen (NEOG) is a Great Momentum Stock: Should You Buy? Does Neogen (NEOG) have what it takes to be a top stock pick for momentum investors? Let's find out.
View source ↗ - Newszacks.com·103d ago·Neutral
Surging Earnings Estimates Signal Upside for Neogen (NEOG) Stock Neogen (NEOG) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
View source ↗
Earnings
Thu, Jan 14(in 7 weeks)
Consensus estimate $0.07 per share
Typical surprise +50.0% (median, so one quarter with a near-zero estimate can't distort it)
- Tue, Oct 6$0.08 vs $0.05beat
- Thu, Jul 30$0.09 vs $0.06beat
- Thu, Apr 9$0.09 vs $0.04beat
- Thu, Jan 8$0.10 vs $0.07beat
- Thu, Oct 9$0.04 vs $-0.07beat
- Mon, Jul 28$-2.82 vs $0.08miss
Estimates and results for NEOG via Financial Modeling Prep. Beating consensus says the company cleared the bar analysts set, not that the business grew.
Insider trading
Open-market buys and sells by NEOG officers and directors.
- Bought
- $14k
- Sold
- $115k
7 trades
1 trade
- Yarwood Jeremysold
- Nassif Mikhealbought
- Nassif Mikhealbought
- Nassif Mikhealbought
- Nassif Mikhealbought
- Nassif Mikhealbought
- Nassif Mikhealbought
- Nassif Mikhealbought
92 further Form 4 entries are share awards, option exercises or shares withheld for tax. Those are compensation, not trades, so they are excluded above. Buying is the stronger signal: an insider spends their own money for one reason. Selling has many innocent explanations — tax, diversifying, a house — so it says far less than it appears to. Via SEC filings.
Congress trades
- Greg Gianfortehouse · MT00 · disclosed Nov 9, 2020 (27d later)Sell$1,001 - $15,000
- Donna Shalalahouse · FL27 · disclosed Apr 27, 2020 (308d later)Sell$1,001 - $15,000
- Greg Gianfortehouse · MT00 · disclosed Jul 1, 2019 (19d later)Buy$100,001 - $250,000
Self-reported filings, amounts as brackets. Via Senate/House disclosures.
